Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML
Thomas Oellerich(Goethe University Frankfurt), Jindřich Činátl(Goethe University Frankfurt)
Cited by 82
Related Papers
SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia
|Nature Medicine|2016|184
Hoxa9 and Meis1 Cooperatively Induce Addiction to Syk Signaling by Suppressing miR-146a in Acute Myeloid Leukemia
|Cancer Cell|2017|116
Oncolytic Effects of a Novel Influenza A Virus Expressing Interleukin-15 from the NS Reading Frame
|PLoS ONE|2012|44
SLP-65 Phosphorylation Dynamics Reveals a Functional Basis for Signal Integration by Receptor-proximal Adaptor Proteins
|Molecular & Cellular Proteomics|2009|43
Resistance to nanoparticle albumin-bound paclitaxel is mediated by ABCB1 in urothelial cancer cells
|Oncology Letters|2017|29